Literature DB >> 23577840

Evasion of killing by human antibody and complement through multiple variations in the surface oligosaccharide of Haemophilus influenzae.

Sarah E Clark1, Kara R Eichelberger, Jeffrey N Weiser.   

Abstract

The lipopolysaccharide (LPS) of H. influenzae is highly variable. Much of the structural diversity is derived from phase variation, or high frequency on-off switching, of molecules attached during LPS biosynthesis. In this study, we examined the dynamics of LPS phase variation following exposure to human serum as a source of antibody and complement in multiple H. influenzae isolates. We show that lic2A, lgtC and lex2A switch from phase-off to phase-on following serial passage in human serum. These genes, which control attachment of a galα1-4gal di-galactoside structure (lic2A and lgtC phase-on) or an alternative glucose extension (lex2A phase-on) from the same hexose moiety, reduce binding of bactericidal antibody to conserved inner core LPS structures. The effects of the di-galactoside and alternative glucose extension were also examined in the context of the additional LPS phase variable structures phosphorylcholine (ChoP) and sialic acid. We found that di-galactoside, the alternative glucose extension, ChoP, and sialic acid each contribute independently to bacterial survival in the presence of human complement, and have an additive effect in combination. We propose that LPS phase variable extensions serve to shield conserved inner core structures from recognition by host immune components encountered during infection.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23577840      PMCID: PMC4550093          DOI: 10.1111/mmi.12214

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  46 in total

Review 1.  Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era.

Authors:  Aarti Agrawal; Timothy F Murphy
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

Review 2.  Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs).

Authors:  Sachiko Sato; Christian St-Pierre; Pampa Bhaumik; Julie Nieminen
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

Review 3.  Roles of galectins in infection.

Authors:  Gerardo R Vasta
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

4.  Epidemiology of nasopharyngeal carriage of respiratory bacterial pathogens in children and adults: cross-sectional surveys in a population with high rates of pneumococcal disease.

Authors:  Grant A Mackenzie; Amanda J Leach; Jonathan R Carapetis; Janelle Fisher; Peter S Morris
Journal:  BMC Infect Dis       Date:  2010-10-23       Impact factor: 3.090

5.  Lex2B, a phase-variable glycosyltransferase, adds either a glucose or a galactose to Haemophilus influenzae lipopolysaccharide.

Authors:  M E Deadman; P Hermant; M Engskog; K Makepeace; E R Moxon; E K H Schweda; D W Hood
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

6.  Natural antibody to conserved targets of Haemophilus influenzae limits colonization of the murine nasopharynx.

Authors:  Tracey A Zola; Elena S Lysenko; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2009-05-18       Impact factor: 3.441

Review 7.  Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century.

Authors:  Marina Ulanova; Raymond S W Tsang
Journal:  Infect Genet Evol       Date:  2009-03-18       Impact factor: 3.342

8.  Molecular basis of increased serum resistance among pulmonary isolates of non-typeable Haemophilus influenzae.

Authors:  Shigeki Nakamura; Mikhail Shchepetov; Ankur B Dalia; Sarah E Clark; Timothy F Murphy; Sanjay Sethi; Janet R Gilsdorf; Arnold L Smith; Jeffery N Weiser
Journal:  PLoS Pathog       Date:  2011-01-06       Impact factor: 6.823

9.  Nontypable Haemophilus influenzae displays a prevalent surface structure molecular pattern in clinical isolates.

Authors:  Pau Martí-Lliteras; Antonio López-Gómez; Silvia Mauro; Derek W Hood; Cristina Viadas; Laura Calatayud; Pau Morey; Alain Servin; Josefina Liñares; Antonio Oliver; José Antonio Bengoechea; Junkal Garmendia
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

10.  Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae.

Authors:  Sarah E Clark; Julian Snow; Jianjun Li; Tracey A Zola; Jeffrey N Weiser
Journal:  PLoS Pathog       Date:  2012-03-01       Impact factor: 6.823

View more
  17 in total

1.  Comprehensive Proteomic and Metabolomic Signatures of Nontypeable Haemophilus influenzae-Induced Acute Otitis Media Reveal Bacterial Aerobic Respiration in an Immunosuppressed Environment.

Authors:  Alistair Harrison; Laura G Dubois; Lisa St John-Williams; M Arthur Moseley; Rachael L Hardison; Derek R Heimlich; Alexander Stoddard; Joseph E Kerschner; Sheryl S Justice; J Will Thompson; Kevin M Mason
Journal:  Mol Cell Proteomics       Date:  2015-12-28       Impact factor: 5.911

2.  Resistance to complement-mediated killing and IgM binding to non-typeable Haemophilus influenzae is not altered when ascending from the nasopharynx to the middle ears in children with otitis media.

Authors:  Jeroen D Langereis; Thijs M A van Dongen; Kim Stol; Roderick P Venekamp; Anne G M Schilder; Peter W M Hermans
Journal:  Med Microbiol Immunol       Date:  2013-06-18       Impact factor: 3.402

3.  Underlying Glycans Determine the Ability of Sialylated Lipooligosaccharide To Protect Nontypeable Haemophilus influenzae from Serum IgM and Complement.

Authors:  Mary Darby Jackson; Sandy M Wong; Brian J Akerley
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

Review 4.  Translating Recent Microbiome Insights in Otitis Media into Probiotic Strategies.

Authors:  Marianne F L van den Broek; Ilke De Boeck; Filip Kiekens; An Boudewyns; Olivier M Vanderveken; Sarah Lebeer
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

5.  Nontypeable Haemophilus influenzae Invasive Blood Isolates Are Mainly Phosphorylcholine Negative and Show Decreased Complement-Mediated Killing That Is Associated with Lower Binding of IgM and CRP in Comparison to Colonizing Isolates from the Oropharynx.

Authors:  Jeroen D Langereis; Amelieke J H Cremers; Marloes Vissers; Josine van Beek; Jacques F Meis; Marien I de Jonge
Journal:  Infect Immun       Date:  2019-01-24       Impact factor: 3.441

6.  Relative contributions of lipooligosaccharide inner and outer core modifications to nontypeable Haemophilus influenzae pathogenesis.

Authors:  Pau Morey; Cristina Viadas; Begoña Euba; Derek W Hood; Montserrat Barberán; Carmen Gil; María Jesús Grilló; José Antonio Bengoechea; Junkal Garmendia
Journal:  Infect Immun       Date:  2013-08-26       Impact factor: 3.441

Review 7.  Bacterial genome instability.

Authors:  Elise Darmon; David R F Leach
Journal:  Microbiol Mol Biol Rev       Date:  2014-03       Impact factor: 11.056

8.  Gene content and diversity of the loci encoding biosynthesis of capsular polysaccharides of the 15 serovar reference strains of Haemophilus parasuis.

Authors:  Kate J Howell; Lucy A Weinert; Shi-Lu Luan; Sarah E Peters; Roy R Chaudhuri; David Harris; Oystein Angen; Virginia Aragon; Julian Parkhill; Paul R Langford; Andrew N Rycroft; Brendan W Wren; Alexander W Tucker; Duncan J Maskell
Journal:  J Bacteriol       Date:  2013-07-19       Impact factor: 3.490

9.  Sequencing of bacterial genomes: principles and insights into pathogenesis and development of antibiotics.

Authors:  Eric S Donkor
Journal:  Genes (Basel)       Date:  2013-10-14       Impact factor: 4.096

10.  Selection for phase variation of LOS biosynthetic genes frequently occurs in progression of non-typeable Haemophilus influenzae infection from the nasopharynx to the middle ear of human patients.

Authors:  Kate L Fox; John M Atack; Yogitha N Srikhanta; Anja Eckert; Laura A Novotny; Lauren O Bakaletz; Michael P Jennings
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.